Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Synthesis and pharmacological evaluation of the novel pseudo-symmetrical tamoxifen derivatives as anti-tumor agents.

Synthesis and pharmacological evaluation of the novel pseudo-symmetrical tamoxifen derivatives as anti-tumor agents. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Synthesis and pharmacological evaluation of the novel pseudo-symmetrical tamoxifen derivatives as anti-tumor agents. Abstract Text:

    isamu shiinaIsamu Shiina,yoshiyuki sanoYoshiyuki Sano,kenya nakataKenya Nakata,takaaki kikuchiTakaaki Kikuchi,akane sasakiAkane Sasaki,masahiko ikekitaMasahiko Ikekita,yukitoshi nagaharaYukitoshi Nagahara,yoshimune hasomeYoshimune Hasome,takao yamoriTakao Yamori,kanami yamazakiKanami Yamazaki,isamu shiinaIsamu Shiina,yoshiyuki sanoYoshiyuki Sano,kenya nakataKenya Nakata,takaaki kikuchiTakaaki Kikuchi,akane sasakiAkane Sasaki,masahiko ikekitaMasahiko Ikekita,yukitoshi nagaharaYukitoshi Nagahara,yoshimune hasomeYoshimune Hasome,takao yamoriTakao Yamori,kanami yamazakiKanami Yamazaki,

    Four pseudo-symmetrical tamoxifen derivatives, RID-B (13), RID-C (14), RID-D (15), and bis(dimethylaminophenetole) (16), were synthesized via the novel three-component coupling reaction, and the structure-activity relationships of these pseudo-symmetrical tamoxifen derivatives were examined. It was discovered that 13 and 16 strongly inhibit the viability of the HL-60 human acute promyelocytic leukemia cell line, whereas 14 possesses a medium activity against the same cell line and 15 has no effect on the cell viability. The global anti-tumor activity of 13-16 against a variety of human cancer cells was assessed using a panel of 39 human cancer cell lines (JFCR 39), and it was shown that RID-B (13) strongly inhibited the growth of several cancer cell lines at concentrations of less than 1muM (at 0.38muM for SF-539 [central nervous system], at 0.58muM for HT-29 [colon], at 0.20muM for DMS114 [lung], at 0.21muM for LOX-IMVI [melanoma], and at 0.23muM for MKN74 [stomach]).

    Synthesis and pharmacological evaluation of the novel pseudo-symmetrical tamoxifen derivatives as anti-tumor agents. Publishing Authors By Initials

    i shiinaI Shiina,y sanoY Sano,k nakataK Nakata,t kikuchiT Kikuchi,a sasakiA Sasaki,m ikekitaM Ikekita,y nagaharaY Nagahara,y hasomeY Hasome,t yamoriT Yamori,k yamazakiK Yamazaki,i shiinaI Shiina,y sanoY Sano,k nakataK Nakata,t kikuchiT Kikuchi,a sasakiA Sasaki,m ikekitaM Ikekita,y nagaharaY Nagahara,y hasomeY Hasome,t yamoriT Yamori,k yamazakiK Yamazaki,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Synthesis and pharmacological evaluation of the novel pseudo-symmetrical tamoxifen derivatives as anti-tumor agents. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Biochemical pharmacology

    VOLUME: 75

    Page Numbers: 1014-26

    Journal Abbreviation: Biochem. Pharmacol.

    ISSN: 0006-2952

    DAY: 22

    MONTH: 11

    YEAR: 2007

    Synthesis and pharmacological evaluation of the novel pseudo-symmetrical tamoxifen derivatives as anti-tumor agents. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101032

    Synthesis and pharmacological evaluation of the novel pseudo-symmetrical tamoxifen derivatives as anti-tumor agents. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Synthesis and pharmacological evaluation of the novel pseudo-symmetrical tamoxifen derivatives as anti-tumor agents. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Synthesis and pharmacological evaluation of the novel pseudo-symmetrical tamoxifen derivatives as anti-tumor agents.

    AFFILIATION: Department of Applied Chemistry, Faculty of Science, Tokyo University of Science, Kagurazaka, Shinjuku-ku, Tokyo 162-8601, Japan.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Biochem Pharmacol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Synthesis and pharmacological evaluation of the novel pseudo-symmetrical tamoxifen derivatives as anti-tumor agents Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News